Global Meningococcal Vaccine Market Insights and Forecast to 2027

1 Study Coverage
    1.1 Meningococcal Vaccine Product Introduction
    1.2 Market by Type
        1.2.1 Global Meningococcal Vaccine Market Size Growth Rate by Type
        1.4.2 Quadrivalent
        1.4.3 Bivalent
        1.2.4 Others
    1.3 Market by Application
        1.3.1 Global Meningococcal Vaccine Market Size Growth Rate by Application
        1.3.2 Pneumonia
        1.3.3 Meningitis
        1.3.4 Bacteremia
        1.3.5 Others (Arthritis, Conjunctivitis, Urethritis)
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary
    2.1 Global Meningococcal Vaccine Sales Estimates and Forecasts 2016-2027
    2.2 Global Meningococcal Vaccine Revenue Estimates and Forecasts 2016-2027
    2.3 Global Meningococcal Vaccine Revenue by Region: 2016 VS 2021 VS 2027
    2.4 Global Top Meningococcal Vaccine Regions by Sales
        2.4.1 Global Top Meningococcal Vaccine Regions by Sales (2016-2021)
        2.4.2 Global Top Meningococcal Vaccine Regions by Sales (2022-2027)
    2.5 Global Top Meningococcal Vaccine Regions by Revenue
        2.5.1 Global Top Meningococcal Vaccine Regions by Revenue (2016-2021)
        2.5.2 Global Top Meningococcal Vaccine Regions by Revenue (2022-2027)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Meningococcal Vaccine Sales by Manufacturers
        3.1.1 Global Top Meningococcal Vaccine Manufacturers by Sales (2016-2021)
        3.1.2 Global Top Meningococcal Vaccine Manufacturers Market Share by Sales (2016-2021)
        3.1.3 Global Top 10 and Top 5 Companies by Meningococcal Vaccine Sales in 2020
    3.2 Global Meningococcal Vaccine Revenue by Manufacturers
        3.2.1 Global Top Meningococcal Vaccine Manufacturers by Revenue (2016-2021)
        3.2.2 Global Top Meningococcal Vaccine Manufacturers Market Share by Revenue (2016-2021)
        3.2.3 Global Top 10 and Top 5 Companies by Meningococcal Vaccine Revenue in 2020
    3.3 Global Meningococcal Vaccine Sales Price by Manufacturers
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Meningococcal Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Meningococcal Vaccine Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
    4.1 Global Meningococcal Vaccine Sales by Type
        4.1.1 Global Meningococcal Vaccine Historical Sales by Type (2016-2021)
        4.1.2 Global Meningococcal Vaccine Forecasted Sales by Type (2022-2027)
        4.1.3 Global Meningococcal Vaccine Sales Market Share by Type (2016-2027)
    4.2 Global Meningococcal Vaccine Revenue by Type
        4.2.1 Global Meningococcal Vaccine Historical Revenue by Type (2016-2021)
        4.2.2 Global Meningococcal Vaccine Forecasted Revenue by Type (2022-2027)
        4.2.3 Global Meningococcal Vaccine Revenue Market Share by Type (2016-2027)
    4.3 Global Meningococcal Vaccine Price by Type
        4.3.1 Global Meningococcal Vaccine Price by Type (2016-2021)
        4.3.2 Global Meningococcal Vaccine Price Forecast by Type (2022-2027)
5 Market Size by Application
    5.1 Global Meningococcal Vaccine Sales by Application
        5.1.1 Global Meningococcal Vaccine Historical Sales by Application (2016-2021)
        5.1.2 Global Meningococcal Vaccine Forecasted Sales by Application (2022-2027)
        5.1.3 Global Meningococcal Vaccine Sales Market Share by Application (2016-2027)
    5.2 Global Meningococcal Vaccine Revenue by Application
        5.2.1 Global Meningococcal Vaccine Historical Revenue by Application (2016-2021)
        5.2.2 Global Meningococcal Vaccine Forecasted Revenue by Application (2022-2027)
        5.2.3 Global Meningococcal Vaccine Revenue Market Share by Application (2016-2027)
    5.3 Global Meningococcal Vaccine Price by Application
        5.3.1 Global Meningococcal Vaccine Price by Application (2016-2021)
        5.3.2 Global Meningococcal Vaccine Price Forecast by Application (2022-2027)

6 North America
    6.1 North America Meningococcal Vaccine Market Size by Type
        6.1.1 North America Meningococcal Vaccine Sales by Type (2016-2027)
        6.1.2 North America Meningococcal Vaccine Revenue by Type (2016-2027)
    6.2 North America Meningococcal Vaccine Market Size by Application
        6.2.1 North America Meningococcal Vaccine Sales by Application (2016-2027)
        6.2.2 North America Meningococcal Vaccine Revenue by Application (2016-2027)
    6.3 North America Meningococcal Vaccine Market Size by Country
        6.3.1 North America Meningococcal Vaccine Sales by Country (2016-2027)
        6.3.2 North America Meningococcal Vaccine Revenue by Country (2016-2027)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Meningococcal Vaccine Market Size by Type
        7.1.1 Europe Meningococcal Vaccine Sales by Type (2017-2027)
        7.1.2 Europe Meningococcal Vaccine Revenue by Type (2017-2027)
    7.2 Europe Meningococcal Vaccine Market Size by Application
        7.2.1 Europe Meningococcal Vaccine Sales by Application (2017-2027)
        7.2.2 Europe Meningococcal Vaccine Revenue by Application (2017-2027)
    7.3 Europe Meningococcal Vaccine Market Size by Country
        7.3.1 Europe Meningococcal Vaccine Sales by Country (2017-2027)
        7.3.2 Europe Meningococcal Vaccine Revenue by Country (2017-2027)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Meningococcal Vaccine Market Size by Type
        8.1.1 Asia Pacific Meningococcal Vaccine Sales by Type (2018-2027)
        8.1.2 Asia Pacific Meningococcal Vaccine Revenue by Type (2018-2027)
    8.2 Asia Pacific Meningococcal Vaccine Market Size by Application
        8.2.1 Asia Pacific Meningococcal Vaccine Sales by Application (2018-2027)
        8.2.2 Asia Pacific Meningococcal Vaccine Revenue by Application (2018-2027)
    8.3 Asia Pacific Meningococcal Vaccine Market Size by Region
        8.3.1 Asia Pacific Meningococcal Vaccine Sales by Region (2018-2027)
        8.3.2 Asia Pacific Meningococcal Vaccine Revenue by Region (2018-2027)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Meningococcal Vaccine Market Size by Type
        9.1.1 Latin America Meningococcal Vaccine Sales by Type (2019-2027)
        9.1.2 Latin America Meningococcal Vaccine Revenue by Type (2019-2027)
    9.2 Latin America Meningococcal Vaccine Market Size by Application
        9.2.1 Latin America Meningococcal Vaccine Sales by Application (2019-2027)
        9.2.2 Latin America Meningococcal Vaccine Revenue by Application (2019-2027)
    9.3 Latin America Meningococcal Vaccine Market Size by Country
        9.3.1 Latin America Meningococcal Vaccine Sales by Country (2019-2027)
        9.3.2 Latin America Meningococcal Vaccine Revenue by Country (2019-2027)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
6 Middle East and Africa
    6.1 Middle East and Africa Meningococcal Vaccine Market Size by Type
        6.1.1 Middle East and Africa Meningococcal Vaccine Sales by Type (2016-2027)
        6.1.2 Middle East and Africa Meningococcal Vaccine Revenue by Type (2016-2027)
    6.2 Middle East and Africa Meningococcal Vaccine Market Size by Application
        6.2.1 Middle East and Africa Meningococcal Vaccine Sales by Application (2016-2027)
        6.2.2 Middle East and Africa Meningococcal Vaccine Revenue by Application (2016-2027)
    6.3 Middle East and Africa Meningococcal Vaccine Market Size by Country
        6.3.1 Middle East and Africa Meningococcal Vaccine Sales by Country (2016-2027)
        6.3.2 Middle East and Africa Meningococcal Vaccine Revenue by Country (2016-2027)
        6.3.3 Turkey
        6.3.4 Saudi Arabia
        6.3.5 U.A.E

11 Company Profiles
    11.1 Novartis
        11.1.1 Novartis Corporation Information
        11.1.2 Novartis Overview
        11.1.3 Novartis Meningococcal Vaccine Sales, Price, Revenue and Gross Margin (2016-2021)
        11.1.4 Novartis Meningococcal Vaccine Product Description
        11.1.5 Novartis Related Developments
    11.2 GSK
        11.2.1 GSK Corporation Information
        11.2.2 GSK Overview
        11.2.3 GSK Meningococcal Vaccine Sales, Price, Revenue and Gross Margin (2016-2021)
        11.2.4 GSK Meningococcal Vaccine Product Description
        11.2.5 GSK Related Developments
    11.3 Merck
        11.3.1 Merck Corporation Information
        11.3.2 Merck Overview
        11.3.3 Merck Meningococcal Vaccine Sales, Price, Revenue and Gross Margin (2016-2021)
        11.3.4 Merck Meningococcal Vaccine Product Description
        11.3.5 Merck Related Developments
    11.4 CSL
        11.4.1 CSL Corporation Information
        11.4.2 CSL Overview
        11.4.3 CSL Meningococcal Vaccine Sales, Price, Revenue and Gross Margin (2016-2021)
        11.4.4 CSL Meningococcal Vaccine Product Description
        11.4.5 CSL Related Developments
    11.5 Baxter
        11.5.1 Baxter Corporation Information
        11.5.2 Baxter Overview
        11.5.3 Baxter Meningococcal Vaccine Sales, Price, Revenue and Gross Margin (2016-2021)
        11.5.4 Baxter Meningococcal Vaccine Product Description
        11.5.5 Baxter Related Developments
    11.6 JN International Medical Corporation
        11.6.1 JN International Medical Corporation Corporation Information
        11.6.2 JN International Medical Corporation Overview
        11.6.3 JN International Medical Corporation Meningococcal Vaccine Sales, Price, Revenue and Gross Margin (2016-2021)
        11.6.4 JN International Medical Corporation Meningococcal Vaccine Product Description
        11.6.5 JN International Medical Corporation Related Developments
    11.7 Serum Institute of India
        11.7.1 Serum Institute of India Corporation Information
        11.7.2 Serum Institute of India Overview
        11.7.3 Serum Institute of India Meningococcal Vaccine Sales, Price, Revenue and Gross Margin (2016-2021)
        11.7.4 Serum Institute of India Meningococcal Vaccine Product Description
        11.7.5 Serum Institute of India Related Developments
    11.8 Bio-Med
        11.8.1 Bio-Med Corporation Information
        11.8.2 Bio-Med Overview
        11.8.3 Bio-Med Meningococcal Vaccine Sales, Price, Revenue and Gross Margin (2016-2021)
        11.8.4 Bio-Med Meningococcal Vaccine Product Description
        11.8.5 Bio-Med Related Developments
    11.9 China National Biotec Group
        11.9.1 China National Biotec Group Corporation Information
        11.9.2 China National Biotec Group Overview
        11.9.3 China National Biotec Group Meningococcal Vaccine Sales, Price, Revenue and Gross Margin (2016-2021)
        11.9.4 China National Biotec Group Meningococcal Vaccine Product Description
        11.9.5 China National Biotec Group Related Developments
    11.10 Hualan Bio
        11.10.1 Hualan Bio Corporation Information
        11.10.2 Hualan Bio Overview
        11.10.3 Hualan Bio Meningococcal Vaccine Sales, Price, Revenue and Gross Margin (2016-2021)
        11.10.4 Hualan Bio Meningococcal Vaccine Product Description
        11.10.5 Hualan Bio Related Developments
    11.1 Novartis
        11.1.1 Novartis Corporation Information
        11.1.2 Novartis Overview
        11.1.3 Novartis Meningococcal Vaccine Sales, Price, Revenue and Gross Margin (2016-2021)
        11.1.4 Novartis Meningococcal Vaccine Product Description
        11.1.5 Novartis Related Developments
    11.12 Zhifei
        11.12.1 Zhifei Corporation Information
        11.12.2 Zhifei Overview
        11.12.3 Zhifei Meningococcal Vaccine Sales, Price, Revenue and Gross Margin (2016-2021)
        11.12.4 Zhifei Product Description
        11.12.5 Zhifei Related Developments

12 Value Chain and Sales Channels Analysis
    12.1 Meningococcal Vaccine Value Chain Analysis
    12.2 Meningococcal Vaccine Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Meningococcal Vaccine Production Mode & Process
    12.4 Meningococcal Vaccine Sales and Marketing
        12.4.1 Meningococcal Vaccine Sales Channels
        12.4.2 Meningococcal Vaccine Distributors
    12.5 Meningococcal Vaccine Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Meningococcal Vaccine Industry Trends
    13.2 Meningococcal Vaccine Market Drivers
    13.3 Meningococcal Vaccine Market Challenges
    13.4 Meningococcal Vaccine Market Restraints

14 Key Findings in The Global Meningococcal Vaccine Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer